← Leaderboards
Raiees Ahmad Andrabi
Scripps Research Institute, The
$11,723,355
Attributed
$20,206,877
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.3M · FY2021–25$20M$15M$10M$5M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,418,716 · 9
By mechanism
R01$9,446,743 · 3
U19$5,673,315 · 3
R61$4,748,429 · 1
R33$3,245,040 · 1
P01$1,305,189 · 1
Top collaborators
- George M Shaw11 shared
- Bryan Briney4 shared
- John Scribner Schieffelin4 shared
- Andrew Barrett Ward4 shared
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- Bryan Briney$10,229,828
- Andrew Barrett Ward$14,394,344
- Paula M Cannon$25,669,125
- Michael B Zwick$21,835,418
- Kenneth Michael Pollard$20,670,399
Others in their field
Other Emerging Leaders on “Vaccines”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$149,372,007
- Kimberly Smith · Ppd Development Lp$115,671,664
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
- Yunda Huang · Fred Hutchinson Cancer Center$74,099,786
- Ted Ross · University Of Georgia$71,962,304
Research focus
VaccinesSiteAntigensNeutralizing AntibodyVaccine DesignB-LymphocytesMolecularEpitopesAntibodiesPropertyBindingAntibody ResponseDesignInfectionResponseAffinityVaccine EvaluationEngineeringIn VivoElementsImmunoglobulin Somatic HypermutationStructureTranslatingVariant
Grant awards (24)
Rationally designed targeted immunogens to elicit HIV Envelope V2-apex broadly neutralizing antibodies$4,211,839
U19 · FY2025 · AI · contact PI
Combining germline-targeting, B cell immunofocusing and Env-Ab coevolution strategies to induce HIV Envelope V2-apex broadly neutralizing antibodies$1,606,895
R33 · FY2025 · AI · contact PI
Project 1: Rational design of targeted vaccines to induce HIV V2-apex bnAb responses$1,225,307
U19 · FY2025 · AI · contact PI
B cell lineage directed rational vaccine strategies based on CAP256SU Env-Ab coevolution$960,412
R01 · FY2025 · AI · contact PI
Genetic, structural and functional profiling of the human antibody response to arenavirus infection$899,311
R01 · FY2025 · AI
Development of pan-betacoronavirus vaccines$709,989
R01 · FY2025 · AI · contact PI
Project 1: Immunogen Design and Delivery$428,319
P01 · FY2025 · AI · contact PI
UPenn - Admin Core$236,169
U19 · FY2025 · AI · contact PI
Combining germline-targeting, B cell immunofocusing and Env-Ab coevolution strategies to induce HIV Envelope V2-apex broadly neutralizing antibodies$1,638,145
R33 · FY2024 · AI · contact PI
B cell lineage directed rational vaccine strategies based on CAP256SU Env-Ab coevolution$960,412
R01 · FY2024 · AI · contact PI
Genetic, structural and functional profiling of the human antibody response to arenavirus infection$872,522
R01 · FY2024 · AI
Development of pan-betacoronavirus vaccines$722,284
R01 · FY2024 · AI · contact PI
Project 1: Immunogen Design and Delivery$428,300
P01 · FY2024 · AI · contact PI
Combining germline-targeting, B cell immunofocusing and Env-Ab co-evolution strategies to induce HIV Envelope V2-apex broadly neutralizing antibodies$1,134,239
R61 · FY2023 · AI · contact PI
Genetic, structural and functional profiling of the human antibody response to arenavirus infection$870,348
R01 · FY2023 · AI
Development of pan-betacoronavirus vaccines$805,612
R01 · FY2023 · AI · contact PI
B cell lineage directed rational vaccine strategies based on CAP256SU Env-Ab coevolution$743,559
R01 · FY2023 · AI · contact PI
Combining germline-targeting, B cell immunofocusing and Env-Ab coevolution strategies to induce HIV Envelope V2-apex broadly neutralizing antibodies$490,507
R61 · FY2023 · AI · contact PI
Project 1: Immunogen Design and Delivery$448,570
P01 · FY2023 · AI · contact PI
B cell lineage directed rational vaccine strategies based on CAP256SU Env-Ab coevolution$133,449
R01 · FY2023 · AI · contact PI
Combining germline-targeting, B cell immunofocusing and Env-Ab co-evolution strategies to induce HIV Envelope V2-apex broadly neutralizing antibodies$1,618,119
R61 · FY2022 · AI · contact PI
Genetic, structural and functional profiling of the human antibody response to arenavirus infection$887,255
R01 · FY2022 · AI
B cell lineage directed rational vaccine strategies based on CAP256SU Env-Ab coevolution$881,590
R01 · FY2022 · AI · contact PI
Combining germline-targeting, B cell immunofocusing and Env-Ab co-evolution strategies to induce HIV Envelope V2-apex broadly neutralizing antibodies$1,505,564
R61 · FY2021 · AI · contact PI